In the build up to the Big Data Analytics in Pharma Summit, Andrea Charles, Editor at Pharma IQ spoke to Nigel Hughes, Director Integrative Healthcare Informatics, Janssen R&D, to take closer look at how access to external data is critical in today’s world and the ways data accessibility can provide pharmaceutical companies with a competitive advantage.
With large scale initiatives coming into practice, such as the European Medical Information Framework (EMIF; www.emif.eu), Hughes shares his top tips for implementing a project like this. Read this interview to find out the key opportunities and threats of utilising real world data and how the rise of personalised/ precision medicine will impact the use of data.
|
|
|
Have Your Say Rate this feature and give us your feedback in the comments section below |